Evidence map›Paper›PMID 36140415›Full record

ArticleBiomedicines2022

Choroidal and Retinal Thicknesses in Type 2 Diabetes Mellitus with Moderate Diabetic Retinopathy Measured by Swept Source OCT.

Guisela Fernández-Espinosa, Elvira Orduna-Hospital, Ana Boned-Murillo, Maria Dolores Diaz-Barreda, Ana Sanchez-Cano, María Sopeña-Pinilla, Isabel Pinilla

Abstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guisela Fernández-EspinosaAragon Institute for Health Research (IIS Aragon), 50009 Zaragoza, Spain.ORCID 0000-0003-1234-9712
Elvira Orduna-HospitalAragon Institute for Health Research (IIS Aragon), 50009 Zaragoza, Spain.ORCID 0000-0003-2710-1875
Ana Boned-MurilloAragon Institute for Health Research (IIS Aragon), 50009 Zaragoza, Spain.
Maria Dolores Diaz-BarredaAragon Institute for Health Research (IIS Aragon), 50009 Zaragoza, Spain.
Ana Sanchez-CanoAragon Institute for Health Research (IIS Aragon), 50009 Zaragoza, Spain.ORCID 0000-0002-5621-1937
María Sopeña-PinillaDepartment of Ophthalmology, Miguel-Servet University Hospital, 50009 Zaragoza, Spain.
Isabel PinillaAragon Institute for Health Research (IIS Aragon), 50009 Zaragoza, Spain.ORCID 0000-0003-0349-9997

Funding

Gobierno de Aragón B08_20RInstituto de Salud Carlos III PI20/00740
6 · The paper itself

Abstract

backgroundTo study choroidal thickness (CT) in type 2 diabetes mellitus (DM2) patients with moderate diabetic retinopathy (DR) and to correlate with changes in retinal thickness (RT) with swept-source OCT (SS-OCT) compared to healthy subjects.

methodsFifty-four DM2 patients with moderate DR without diabetic macular edema (DME) and 73 age-matched healthy subjects were evaluated using SS-OCT to measure changes in total RT and CT in the nine areas of the Early Treatment Diabetic Retinopathy Study (ETDRS) macular grid.

resultsThe mean age was 64.06 ± 11.98 years and 60.79 ± 8.62 years in the diabetic and control groups, respectively. Total RT showed statistically significant differences in the temporal inner area, with higher values in the DM2 group (

conclusionDM2 patients with moderate DR have no changes with regard to CT. Both CT and RT decreased with age in DM2, showing a negative correlation between these factors in the central and horizontal parafoveal areas of the ETDRS grid.

Indexed as

choroidal thicknessdiabetic retinopathyretinal thicknessswept-source optical coherence tomographytype 2 diabetes mellitus

Identifiers

PMID36140415
PMCPMC9496206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.